DPYSL5 and lung carcinoma: Cancer predictive antibodies included CRMP-5 (4 patients: 1 case of tonsillar squamous cell, 2 mixed histology lung carcinomas and 1 SCLC), ANNA-1 (3 patients: 2 with lung carcinoma and 1 bladder carcinoma), followed by ANNA-2 (Ri) and amphiphysin antibodies in a patient with SCLC.